Search results
1st International SynBYSS Conference. Brining together the synthetic biology community with an explicit goal to invest in the young, diverse, and international future of synthetic biology. Join us December 9-12, 2024 at the University of Hawaiʻi at Mānoa.
- About
J. Craig Venter Institute culture is founded on the...
- Research
J. Craig Venter Institute and UC San Diego Develop Phage...
- Publications
Publications from the J. Craig Venter Institute. Rothschild...
- Blog
J. Craig Venter Institute contracted by the Centers for...
- Careers
The J. Craig Venter Institute is committed to providing...
- Contact
J. Craig Venter Institute 4120 Capricorn Lane La Jolla, CA...
- Donate
The J. Craig Venter Institute (JCVI) has a long history of...
- Environmental Sustainability
Viking’s Initiative with UC San Diego’s Scripps Institution...
- About
John Craig Venter (born October 14, 1946) is an American biotechnologist and businessman. He is known for leading one of the first draft sequences of the human genome [1] [2] and assembled the first team to transfect a cell with a synthetic chromosome.
J. Craig Venter, PhD. Founder, Chairman, and Chief Executive Officer. 858-200-1890. Bio. Publications. Projects. Video. News.
J. Craig Venter Institute culture is founded on the principles of diversity, equity, and inclusion (DEI). We are focused on creating a community where we are able to share, learn, grow, and develop together in a respectful, productive manner.
J. Craig Venter is a biologist most known for his contributions, in 2001, of sequencing the first draft human genome and in 2007 for the first complete diploid human genome. In 2010 he and his...
- 16 min
- 126K
- TEDx Talks
The J. Craig Venter Institute ( JCVI) is a non-profit genomics research institute founded by J. Craig Venter, Ph.D. in October 2006.
J. Craig Venter (born Oct. 14, 1946, Salt Lake City, Utah, U.S.) is an American geneticist, biochemist, and businessman who pioneered new techniques in genetics and genomics research and headed the private-sector enterprise, Celera Genomics, in the Human Genome Project (HGP).
